Zimmer Biomet is set to feature at the december's Citi Global Healthcare Conference. They also announced CE Mark Certification for their Persona Revision Knee System.
Several entities such as Studio Investment Management LLC and Landscape Capital Management L.L.C. have increased their stakes in Zimmer Biomet, while others like Quest Partners LLC and Mutual of America Capital Management LLC lowered their holdings.
The Biotech firm's stock has unfortunately underperformed this week compared with its competitors. Their Q3 2024 revenue growth was reported to be strong despite missing Q3 earnings estimates. Zimmer Biomet's stock pricing did not fully recover with the market's overall growth.
Arnold Schwarzenegger has joined as the Chief Movement Officer in a significant partnership, that seems to have received mixed reactions on Wall Street.
ZBH launched their strategic alliance with NeuroOne and their Z1 Hip System. Their top-rated Knee Revision System also received the CE Mark for European expansion.
On the negative side, Zimmer's stock took a hit due to software system issues impacting sales, downgrading the annual forecasts. However, some see Zimmer as a 'Strong Value Stock' because of this dip.
Zimmer Biomet Holdings ZBH News Analytics from Thu, 08 Feb 2024 08:00:00 GMT to Sat, 23 Nov 2024 14:40:22 GMT - Rating 4 - Innovation 8 - Information 6 - Rumor -5
